A new study found that a mobile-based app could be an effective way of monitoring age-related mucular degeneration (AMD) and diabetic retinopathy. A study recently presented at the American Academy of Ophthalmology or AAO, reported that patients who used DigiSight's Paxos Checkup app, got comparable results to those who had traditional clinical checkups.
Correction: This paragraph has been...
DigiSight Technologies has launched a new version of its smartphone-based eyesight test and a new offering called Scope, a hardware-software combined system that allows a medical professional to use the smartphone camera to photograph the back and front of the patient's eye.
Formerly, DigiSight offered an iOS app called Sightbook that delivered at-home vision screening using an iPhone app. It was...
DigiSight Technologies, a California-based company currently focused on mobile apps for ophthalmology, has raised $7.8 million in second round financing. The round was led by Biosys Capital, Waycross Ventures, GE Ventures, and Lagunita, with additional contributions from existing investors.
The company's core technology is the DigiSight Network, a platform for connecting data from patients'...
